BD 231633 - Sensi-Disc Ceftazidime 30g Antibiotic Susceptibility Testing Disc, 10/BX
The BD 231633 Sensi-Disc Ceftazidime 30g is a precision-manufactured antimicrobial susceptibility testing (AST) disc used in the standardized Kirby-Bauer disk diffusion method. Produced by BD (Becton Dickinson), a global leader in microbiological diagnostics, this disc is designed to determine bacterial susceptibility to ceftazidime, a third-generation cephalosporin antibiotic widely used in treating Gram-negative bacterial infections. Each disc contains 30 micrograms of ceftazidime and provides reliable, reproducible inhibition zone results when tested on Mueller-Hinton Agar (MHA). This diagnostic tool is essential for identifying resistant strains and guiding effective antibiotic therapy in clinical microbiology laboratories.
| Manufacturer | 231633 |
| Antimicrobial Agent | Ceftazidime |
| Application | Antimicrobial Susceptibility Testing Disc |
| Disc Potency | 30 g |
Key Benefits
The BD Sensi-Disc Ceftazidime 30g offers consistent and dependable results for antimicrobial susceptibility testing. Its uniform antibiotic distribution ensures precise diffusion patterns and reproducible inhibition zones. Each disc is individually tested for potency and quality, meeting CLSI (Clinical and Laboratory Standards Institute) standards for accuracy. The discs are packaged in moisture-resistant cartridges that preserve antibiotic stability, ensuring consistent results even after extended storage. With BDs industry-leading quality control, laboratories can rely on these discs for detecting ceftazidime-resistant organisms, including extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae.
Compatibility and Applications
The BD 231633 Ceftazidime 30g Sensi-Disc is compatible with the Kirby-Bauer disk diffusion testing method and is used on Mueller-Hinton Agar plates. It is suitable for determining the susceptibility of Gram-negative bacteria such as Pseudomonas aeruginosa, Escherichia coli, Klebsiella spp., Enterobacter spp., and other members of the Enterobacteriaceae family. The disc is used in hospital and clinical laboratories, pharmaceutical quality control, and research settings for routine AST, resistance monitoring, and antibiotic development testing.
Usage Guidelines
Prepare a bacterial suspension adjusted to a 0.5 McFarland standard and inoculate evenly onto a Mueller-Hinton Agar plate using a sterile swab. Using sterile forceps or a BD Sensi-Disc dispenser, place the BD 231633 Ceftazidime 30g disc on the agar surface. Incubate the plate at 352C for 1618 hours in ambient air. After incubation, measure the diameter of the inhibition zone in millimeters and interpret the results according to current CLSI or EUCAST guidelines. Always include appropriate control strains such as Escherichia coli ATCC 25922 and Pseudomonas aeruginosa ATCC 27853 for quality control validation.
Certifications, Safety Standards, and Regulatory Approvals
The BD 231633 Sensi-Disc Ceftazidime 30g complies with ISO 13485 and ISO 9001 quality management standards. It is FDA-cleared and CE-marked for in vitro diagnostic (IVD) use and manufactured in compliance with Good Manufacturing Practices (GMP). Each lot undergoes rigorous quality testing for potency, diffusion consistency, sterility, and stability. BD ensures traceability and compliance with CLSI methodology to guarantee accurate and reproducible antimicrobial susceptibility results for clinical use.
Comparison with Competitor Products
Compared to competitor antibiotic discs, BD Sensi-Discs deliver superior consistency, reliability, and ease of use. Competitor discs may exhibit uneven antibiotic diffusion or variability in potency due to substandard manufacturing processes. BDs proprietary production technology ensures precise antibiotic loading, stable storage, and reliable zone uniformity. The moisture-resistant cartridge packaging extends shelf life and maintains performance integrity. Laboratories worldwide prefer BD Sensi-Discs for their proven reliability in antimicrobial susceptibility testing and infection control diagnostics.
Typical User Profile and Application Scenarios
This product is designed for use by clinical microbiologists, laboratory technologists, and researchers conducting antimicrobial resistance testing. It is widely used in hospital diagnostic laboratories, research facilities, and public health institutions involved in resistance surveillance. The BD 231633 Ceftazidime 30g Sensi-Disc is essential for identifying multidrug-resistant Gram-negative pathogens and guiding targeted antibiotic therapy, particularly in cases involving Pseudomonas or Enterobacteriaceae infections.
Best Practices for Use and Maintenance
Store the discs at 28C in their original sealed packaging to maintain potency. Before opening, allow the package to equilibrate to room temperature (2025C) to prevent moisture condensation. Handle discs using sterile forceps or an automatic dispenser to avoid contamination. Use freshly prepared, quality-controlled Mueller-Hinton Agar and standardized inoculum suspensions for accurate results. Discard expired or damaged discs and ensure proper calibration of measuring tools for zone interpretation. Regularly verify disc performance using recommended control organisms to ensure consistent laboratory accuracy.
Regulatory and Safety Information
This product is intended for professional laboratory use only. Handle all bacterial isolates as potentially infectious materials under Biosafety Level 2 (BSL-2) precautions. Use appropriate personal protective equipment (PPE), including gloves, laboratory coats, and eye protection. Dispose of used discs and culture plates by autoclaving or following institutional biosafety protocols. Refer to the Safety Data Sheet (SDS) for additional handling, storage, and disposal guidance. BD guarantees that all Sensi-Disc products meet international standards for safety, performance, and environmental responsibility.
How to Order
To purchase the BD 231633 Sensi-Disc Ceftazidime 30g, add the product to your cart and complete the secure checkout process on the CIA Medical website. For institutional or bulk orders, contact CIA Medical customer service at (312) 275-5850 or submit an inquiry via the online contact form. CIA Medical provides competitive pricing, fast shipping, and professional support for all BD Sensi-Disc antimicrobial susceptibility testing products.
